UroosaIbrahimMD

Hematology • New York, NY

Hematologic Oncology, Myeloproliferative Disorder Hematology-Oncology

Physician

Join to view full profile

Dr. Ibrahim is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ibrahim's full profile

Already have an account?

Office
1 Gustave L. Levy Pl
New York, NY 10029

Education & Training

Ziauddin Medical UniversityClass of 2009

Certifications & Licensure

NY State Medical License 2015 - 2026
NJ State Medical License 2018 - 2019
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

HIV Antigen-specific T-cells Targeting Conserved Epitopes (HST-NEETs) BMTCTN1903 Start of enrollment: 2021 Oct 25
Recruiting
Phase 2
Roles: Contact

Publications & Presentations

PubMed

3 citations
SARS-CoV-2 Vaccination in the First Year After Hematopoietic Cell Transplant or Chimeric Antigen Receptor T-Cell Therapy: A Prospective, Multicenter, Observational Study.
Joshua A Hill, Michael J Martens, Jo-Anne H Young, Kavita Bhavsar, Jianqun Kou
Clinical Infectious Diseases. 2024-08-16
Dynamics of cytomegalovirus-specific T-cell recovery in allogeneic hematopoietic cell transplant recipients using a commercially available flow cytometry assay: A pilo...
Samantha E Jacobs, Uroosa Ibrahim, Akasha Barreto Vega, Jonathan Lagdameo, Jacquelyn Callahan
Transplant Infectious Disease. 2024-06-01
1 citations
SARS-CoV-2 vaccination in the first year after hematopoietic cell transplant or chimeric antigen receptor T cell therapy: A prospective, multicenter, observational stu...
Joshua A Hill, Michael J Martens, Jo-Anne H Young, Kavita Bhavsar, Jianqun Kou
Medrxiv. 2024-01-25